Case Study 1: Finance and Medicine -- When the People Who Decide Are Not the People Who Suffer

"It is difficult to get a man to understand something, when his salary depends on his not understanding it." -- Upton Sinclair -- a sentence that, in skin-in-the-game terms, describes the informational corruption produced when consequence-bearing is misaligned with decision-making

Two Systems, One Structural Failure

This case study examines the skin-in-the-game failure in two domains that seem superficially different but are structurally identical: the American financial system in the years leading to the 2008 crisis, and the American healthcare system in its chronic misalignment between physician decisions and patient outcomes. In both cases, a chain of delegation separates the decision-maker from the consequence-bearer. In both cases, the separation produces not just bad incentives but corrupted information. And in both cases, the structural failure was visible in advance to anyone who understood the principle -- yet persisted because the people who benefited from the asymmetry had the power to maintain it.

Part I: The Financial System -- A Chain of Transferred Consequences

The Architecture of Asymmetry

To understand the 2008 financial crisis as a skin-in-the-game failure, you must first understand the architecture of the mortgage securitization chain. It had five links, and at each link, the skin was in a different game.

Link 1: The Borrower. A family wants to buy a house. They apply for a mortgage. The borrower has the most skin in the game of anyone in the chain -- if the mortgage becomes unaffordable, the borrower loses the house, the savings, the credit score, potentially everything. The borrower's decision to take on the mortgage is, in the chapter's framework, a relatively honest signal: it reflects a genuine (if sometimes optimistic) belief that they can make the payments.

Link 2: The Mortgage Originator. A company -- often not a bank but a mortgage broker or a specialized lending company -- approves the loan and issues the mortgage. In the traditional model, the originator would hold the mortgage for its full term: if the borrower defaulted, the originator would bear the loss. This gave the originator strong skin in the game and incentivized careful assessment of the borrower's ability to repay.

But by the early 2000s, the traditional model had been replaced by the "originate-to-distribute" model: the originator issued the mortgage with the intention of selling it within weeks. The originator earned a fee on each mortgage originated, regardless of whether the borrower could repay. The originator's skin was no longer in the borrower's ability to repay but in the volume of mortgages originated. The originator's decision to approve or deny a mortgage was no longer an honest signal about the borrower's creditworthiness. It was a signal about the originator's need for transaction volume.

The informational corruption was immediate and measurable. Mortgage originators began approving loans that no reasonable assessment would have approved. NINJA loans -- No Income, No Job, No Assets -- were not failures of oversight. They were the logical consequence of a system in which the person making the lending decision bore no consequence of lending badly. The originator's approval stamp ceased to mean "this borrower can repay" and started to mean "this loan generates a fee."

Link 3: The Investment Bank. The investment bank purchased thousands of mortgages, bundled them into mortgage-backed securities (MBS), and sold the securities to investors. The bank earned fees on the bundling and the sale. The bank's skin was in deal volume and fee income, not in the long-term performance of the securities. A Merrill Lynch banker who structured a collateralized debt obligation (CDO) in 2006 received a bonus based on the size and number of deals closed that year. If the CDO lost all its value in 2008, the banker still kept the 2006 bonus.

The informational corruption was again direct. The bank's decision to bundle certain mortgages into a security was not an honest signal about the quality of those mortgages. It was a signal about the bank's ability to find a buyer. The structure of the security -- the tranching, the diversification, the mathematical modeling of default correlations -- was designed to make the security look attractive to buyers, not to reflect the genuine risk of the underlying mortgages. The packaging was, in the language of the chapter, noise dressed up as signal.

Link 4: The Rating Agency. Moody's, Standard & Poor's, and Fitch assigned credit ratings to the mortgage-backed securities. An AAA rating was supposed to mean that the security was virtually default-proof. The rating agencies' skin was supposed to be in their reputation: if they assigned inaccurate ratings, investors would lose trust and take their business elsewhere. But the agencies were paid by the issuers (the investment banks), not by the investors who relied on the ratings. The agency's revenue depended on maintaining relationships with the banks, which meant assigning the ratings the banks wanted.

The informational corruption was total. A rating that was supposed to be an honest signal about default risk had become a signal about the commercial relationship between the agency and the bank. An AAA rating in 2006 did not tell you that a security was safe. It told you that the issuer had paid the agency to rate it, and that the agency had found a way to justify the desired rating. The information content of the rating had been hollowed out by the absence of skin in the game.

Link 5: The Investor. Pension funds, insurance companies, sovereign wealth funds, and other institutional investors purchased the securities. They relied on the ratings. They trusted the chain. And they bore the consequences when the chain collapsed. The investor had the most skin in the game at the endpoint -- they would suffer the losses -- but the least information about what they were buying, because every link in the chain between them and the borrower had been informationally corrupted by the absence of consequence-bearing.

The Bailout as the Final Asymmetry

When the housing bubble burst in 2007-2008 and the mortgage-backed securities lost most of their value, the investment banks that had created and sold them faced catastrophic losses. Several of the largest -- Bear Stearns, Lehman Brothers, Merrill Lynch -- either failed or were rescued. The rescues were funded by taxpayers -- people who had no say in the decisions that created the crisis and no share in the profits that those decisions generated during the boom years.

The bailout completed the asymmetry. The decision-makers kept their profits. The consequence-bearers absorbed the losses. And the information signal of the entire system -- the collection of market prices, credit ratings, lending decisions, and investment choices that was supposed to tell the economy where resources should be allocated -- was revealed to have been noise for years. Not because the participants were stupid. Not because the regulators were asleep. But because the structural arrangement -- the systematic separation of decision-making from consequence-bearing -- had corrupted the information at every link in the chain.

The Structural Lesson

The financial crisis of 2008 was not primarily a failure of regulation, intelligence, or ethics. It was a failure of skin in the game. At each link in the chain, the person making the decision did not bear the consequences of the decision. This produced two effects: motivational degradation (they didn't try hard enough) and informational degradation (their decisions didn't reflect their genuine beliefs). The second effect was more devastating, because it meant that the entire information infrastructure of the financial system -- the prices, ratings, and assessments that every other participant relied on -- was systematically corrupted.

Part II: The Healthcare System -- A Quieter Catastrophe

The Structural Mismatch

The American healthcare system's skin-in-the-game failure is less dramatic than the financial crisis but arguably more damaging in total, because it is chronic rather than acute. Every day, millions of medical decisions are made by people who bear different consequences from the people those decisions affect. And every day, those decisions are shaped -- subtly, systematically, almost invisibly -- by the mismatch.

The architecture of the mismatch has four components.

The Doctor-Patient Asymmetry. The doctor recommends. The patient endures. The doctor bears legal and professional consequences; the patient bears physical consequences. These are qualitatively different kinds of skin in the game, and they produce qualitatively different decisions.

A 2011 study by researchers at Johns Hopkins surveyed physicians across multiple specialties and found a consistent pattern: when asked what they would choose for themselves, physicians consistently preferred less aggressive treatment than what they recommended for their patients. In scenarios involving terminal illness, physicians were dramatically more likely to choose comfort care for themselves and aggressive intervention for their patients. The gap was not random variation. It was systematic -- a structural divergence between what doctors genuinely believed was wise and what they recommended to patients.

Why? Because the doctor who recommends comfort care and whose patient dies faces a potential malpractice suit. The doctor who recommends aggressive treatment and whose patient dies despite treatment is protected by the standard of care -- they did everything possible. The legal system creates a bias toward action, toward intervention, toward doing more rather than less. This bias does not reflect medical judgment. It reflects legal judgment. The doctor's recommendation has been contaminated by a skin-in-the-game mismatch: the doctor bears legal consequences for under-treatment but not for over-treatment.

The Pharmaceutical Asymmetry. The pharmaceutical company develops and markets a drug. The patient takes the drug. The company bears financial risk (if the drug fails commercially) and legal risk (if the drug causes harm that can be proved in court). But the company does not bear the physical risk. The executives who approve marketing strategies for opioids do not become addicted to opioids. The sales representatives who promote the drugs to physicians do not experience the side effects.

The informational consequence is that the pharmaceutical company's marketing materials do not honestly reflect the drug's risk profile. They are shaped by the company's financial incentives -- to emphasize benefits, minimize risks, and maximize prescriptions. The physician who relies on pharmaceutical company information is receiving information that has been corrupted by the absence of skin in the game. The patient who takes the drug based on the physician's recommendation is two steps removed from honest information -- the pharmaceutical company's information was corrupted by commercial incentives, and the physician's recommendation was corrupted by the legal and professional incentive structure.

The Insurance Asymmetry. Health insurance companies make decisions about what treatments to cover, how much to reimburse, and which claims to approve or deny. These decisions directly affect patient outcomes. But the insurance executive who denies a claim does not experience the medical consequences of that denial. The executive bears financial consequences (the company's profitability) and possibly reputational consequences (public outrage over egregious denials). But the consequences are in a different dimension from the patient's consequences.

The Administrative Asymmetry. Hospital administrators make decisions about staffing levels, equipment purchases, facility design, and treatment protocols. These decisions affect patient safety and care quality. But administrators typically evaluate these decisions through financial and operational metrics -- cost per patient, bed utilization, throughput -- rather than through direct experience of patient outcomes. The administrator who reduces nursing staff to cut costs does not experience the increased medication errors that result. The consequence falls on the patient; the metric improvement falls on the administrator's performance review.

The Cumulative Effect

Each of these asymmetries, taken individually, might seem manageable. Defensive medicine adds unnecessary tests but doesn't kill anyone (directly). Pharmaceutical marketing exaggerates benefits but doesn't force anyone to take a drug. Insurance denial delays treatment but doesn't prevent it entirely (usually). Staffing reductions increase error rates but don't cause catastrophes (most of the time).

But the asymmetries compound. A patient navigating the American healthcare system faces a chain of decision-makers, each with skin in a different game. The doctor's skin is in legal protection. The pharmaceutical company's skin is in market share. The insurance company's skin is in claims minimization. The hospital administrator's skin is in cost management. None of their skin is in the patient's health, at least not in the direct, personal, consequence-bearing sense that Hammurabi's code demanded.

The result is a system that spends more per capita on healthcare than any other developed nation while achieving mediocre outcomes. This is not because American doctors are incompetent, American drugs are ineffective, or American hospitals are poorly equipped. It is because the information flowing through the system -- the recommendations, the marketing, the coverage decisions, the staffing choices -- has been systematically corrupted by skin-in-the-game mismatches at every node.

The Partial Solutions and Their Limits

The healthcare system has tried all three classical solutions to the principal-agent problem:

Monitoring: Medical boards, accreditation agencies, malpractice review, clinical audits. These are expensive and incomplete. They measure what is measurable (procedures performed, documentation completed, protocols followed) rather than what matters (patient outcomes, quality of judgment, appropriateness of treatment). They are vulnerable to Goodhart gaming: the doctor who documents perfectly but decides poorly passes every audit.

Contracting: Pay-for-performance, outcome-based reimbursement, value-based care models. These are theoretically appealing but practically limited. Medical outcomes depend on patient compliance, disease severity, comorbidities, and a thousand other factors beyond the physician's control. Tying compensation to outcomes that the physician cannot fully control creates noise in the signal -- the physician's compensation reflects patient characteristics as much as physician quality.

Skin in the game: Malpractice liability is the closest thing the healthcare system has to genuine skin in the game for physicians. But malpractice liability is a blunt, biased mechanism: it punishes errors of commission (doing something harmful) far more than errors of omission (failing to do something helpful), which incentivizes over-treatment rather than optimal treatment. And it operates with enormous delay -- malpractice cases take years to resolve, during which the information signal is lost in legal noise.

The structural lesson is the same as in finance: monitoring and contracting are patches, not cures. They can reduce the symptoms of the skin-in-the-game mismatch, but they cannot restore the honest information that consequence-bearing naturally produces. The system continues to generate decisions that reflect the decision-makers' incentive structures rather than the decision-makers' genuine beliefs about what is best for the patient.

Cross-Domain Analysis

The parallels between finance and medicine are structural:

The Deeper Connection

Both systems share a structural trajectory: they began with relatively high skin in the game (the local banker who held the mortgage, the family physician who knew the patient for decades), evolved through specialization and scale into systems with low skin in the game (the mortgage securitization chain, the multi-institution healthcare chain), and now face the informational consequences of that evolution.

The evolution was not malicious. It was driven by the same forces that drive all institutional evolution: efficiency, specialization, scale. The local banker who held the mortgage could not finance a national housing boom. The family physician who knew every patient could not manage the complexity of modern medicine. Delegation, specialization, and chain-lengthening were necessary responses to increasing scale and complexity.

But each step in the evolution added a link to the chain, and each link reduced the skin in the game for the decision-makers while transferring consequences further down the line. The result is systems that are more efficient, more specialized, more scalable -- and more informationally corrupted. They produce more decisions per day, but each decision contains less honest information about what the decision-maker genuinely believes is best.

This is the fundamental tradeoff that modern institutions face: scale requires delegation, and delegation destroys skin in the game, and the destruction of skin in the game corrupts the information on which the entire system depends. The question is not whether to scale or not to scale. The question is how to preserve the informational benefits of skin in the game while capturing the efficiency benefits of scale. No modern institution has fully solved this problem. Understanding the problem -- through the lens of the skin-in-the-game principle -- is the first step toward solutions that might.

Discussion Questions

1. The case study traces a structural parallel between the mortgage securitization chain and the healthcare decision chain. Can you identify another multi-link chain in a domain you know well where skin in the game is lost at each link? Map the chain and identify the informational corruption at each step.

2. The 2008 financial crisis was an acute event -- a sudden collapse that revealed the accumulated corruption. Is there an equivalent acute event possible in healthcare, or is the healthcare system's skin-in-the-game failure inherently chronic? What would a healthcare "crisis of 2008" look like?

3. The case study argues that the evolution from local/personal to global/institutional decision-making was necessary but destroyed skin in the game. Is it possible to design large-scale financial or healthcare systems that preserve local-scale skin in the game? What would such a system look like?

4. The pharmaceutical company's asymmetry -- developing drugs for people while bearing financial but not physical consequences -- seems difficult to solve without fundamentally changing the structure of pharmaceutical development. What structural change could restore skin in the game to pharmaceutical decision-making?

5. The chapter's threshold concept is Accountability as Information. Apply it to the question of healthcare reform: if the fundamental problem is not insufficient regulation but corrupted information, what reforms would address the information problem rather than (or in addition to) the regulation problem?